✦ LIBER ✦
PO2-2: An evaluation of the safety and usability of FlexPro® 30 mg/3 mL, for the delivery of Norditropin® in patients requiring growth hormone (GH) therapy
✍ Scribed by Kappelgaard, A.-M.; Wen, Y.; Klinck, R.; Qvist, M.; Fuchs, G.S.
- Book ID
- 126758816
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 436 KB
- Volume
- 24
- Category
- Article
- ISSN
- 1096-6374
No coin nor oath required. For personal study only.